Synendos Therapeutics

Synendos Therapeutics is a biopharmaceutical company aimed at developing breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders by modulating novel drug targets within the endocannabinoid system, which can restore the brain's natural functions. Our mission is to advance the preclinical and clinical development of novel small molecules that act as Selective Endocannabinoid Reuptake Inhibitors (SERIs).